Onkologie. 2017:11(3):138-143 | DOI: 10.36290/xon.2017.027

Malignant melanoma, incidence, risk factor and early diagnosis

Ondřej Kodet1, 2, 3, Ivana Krajsová1
1Dermatovenerologická klinika 1. LF UK a VFN, Praha, 2Anatomický ústav 1. LF UK, Praha, 3BIOCEV – Biotechnologické a biomedicínské centrum Akademie věd a Univerzity Karlovy ve Vestci u Prahy

The incidence of primary cutaneous melanoma in the population continues to grow and reached almost quadruple values for the

last 40 years. It represents a significant health and also socio-economic problem. Long-term survival of patients with melanoma is

significantly dependent on the diagnosis of melanoma in the early stages of the disease, which have better long-term prognosis.

Target screening helps to effectively monitor risk population with tendency for the diagnosis of melanoma in prognostically more

favorable stages. Education of the population and the availability of basic dermatooncology examination play indispensable role

in prevention of melanoma.

Keywords: melanoma, risk factors, screening of population

Published: June 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kodet O, Krajsová I. Malignant melanoma, incidence, risk factor and early diagnosis. Onkologie. 2017;11(3):138-143. doi: 10.36290/xon.2017.027.
Download citation

References

  1. Riley PA, Borovanský J, ebrary Inc. Melanins and melanosomes biosynthesis, biogenesis, physiological, and pathological functions. Weinheim Chichester: Wiley-VCH; John Wiley distributor; 2011. Available from: http://site.ebrary.com/lib/rockefeller/Doc?id=10577628. Go to original source...
  2. Berwick M, Orlow I, Hummer AJ, et al. The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study. Cancer Epidemiol Biomarkers Prev. 2006; 15(8): 1520-1525. Go to original source... Go to PubMed...
  3. Aoude LG, Gartside M, Johansson P, et al. Prevalence of Germline BAP1, CDKN2A, and CDK4 Mutations in an Australian Population-Based Sample of Cutaneous Melanoma Cases. Twin Res Hum Genet. 2015; 18(2): 126-133. Go to original source... Go to PubMed...
  4. Potrony M, Puig-Butille JA, Aguilera P, et al. Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations. JAMA Dermatol. 2016; 152(4): 405-412. Go to original source... Go to PubMed...
  5. Fargnoli MC, Pike K, Pfeiffer RM, et al. MC1R variants increase risk of melanomas harboring BRAF mutations. J Invest Dermatol. 2008; 128(10): 2485-2490. Go to original source... Go to PubMed...
  6. Kraemer KH, Lee MM, Andrews AD, Lambert WC. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol. 1994; 130(8): 1018-1021. Go to original source... Go to PubMed...
  7. Bauer J, Garbe C. Risk estimation for malignant transformation of melanocytic nevi. Arch Dermatol. 2004; 140(1): 127; author reply. Go to original source... Go to PubMed...
  8. Duffy K, Grossman D. The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects. J Am Acad Dermatol. 2012; 67(1):1 e-16; quiz 7-8. Go to original source... Go to PubMed...
  9. Duffy K, Grossman D. The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management. J Am Acad Dermatol. 2012; 67(1): 19 e1-2; quiz 31-32. Go to original source... Go to PubMed...
  10. Vuong K, McGeechan K, Armstrong BK, Investigators A, Investigators GEM, Cust AE. Occupational sun exposure and risk of melanoma according to anatomical site. Int J Cancer. 2014; 134(11): 2735-2741. Go to original source... Go to PubMed...
  11. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009; 27(36): 6199-6206. Go to original source... Go to PubMed...
  12. Shenenberger DW. Cutaneous malignant melanoma: a primary care perspective. Am Fam Physician. 2012; 85(2): 161-168. Go to PubMed...
  13. Anagnostopoulos CN, Vergados DD, Anagnostopoulos I, Mintzias P. Total dermoscopy score calculation using quantitative measurements in digital dermoscopy. Conf Proc IEEE Eng Med Biol Soc. 2014; 2014: 6744-6747. Go to original source... Go to PubMed...
  14. Rao BK, Ahn CS. Dermatoscopy for melanoma and pigmented lesions. Dermatol Clin. 2012; 30(3): 413-434. Go to original source... Go to PubMed...
  15. Barzegari M, Ghaninezhad H, Mansoori P, et al. Computer-aided dermoscopy for diagnosis of melanoma. BMC Dermatol. 2005; 5: 8. Go to original source... Go to PubMed...
  16. Mofarrah R, Ahlgrimm-Siess V, Massone C, et al. Reflectance confocal microscopy: a useful and non-invasive tool in the in vivo differentiation of benign pigmented skin lesions from malignant melanoma. Report of a case. Dermatol Pract Concept. 2013; 3(1): 33-35. Go to original source... Go to PubMed...
  17. Burki TK. Total body exam or lesion detection screening for skin cancer? Lancet Oncol. 2015; 16(16): e590. Go to original source... Go to PubMed...
  18. Piris A, Mihm MC, Jr. Progress in melanoma histopathology and diagnosis. Hematol Oncol Clin North Am. 2009; 23(3): 467-480, viii. Go to original source... Go to PubMed...
  19. Song J, Mooi WJ, Petronic-Rosic V, et al. Nevus versus melanoma: to FISH, or not to FISH. Adv Anat Pathol. 2011; 18(3): 229-234. Go to original source... Go to PubMed...
  20. Geller AC, Sober AJ, Zhang Z, et al. Strategies for improving melanoma education and screening for men age <= 50 years - Findings from the American Academy of Dermatology National Skin Cancer Screening Program. Cancer. 2002; 95(7): 1554-1561. Go to original source... Go to PubMed...
  21. Kefford RF, Newton Bishop JA, Bergman W, et al. Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the Melanoma Genetics Consortium. J Clin Oncol. 1999; 17(10): 3245-3251. Go to original source... Go to PubMed...
  22. Paddock LE, Lu SE, Bandera EV, et al. Skin self-examination and long-term melanoma survival. Melanoma Res. 2016; 26(4): 401-408. Go to original source... Go to PubMed...
  23. Breitbart EW, Waldmann A, Nolte S, et al. Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol. 2012; 66(2): 201-211. Go to original source... Go to PubMed...
  24. Stang A, Jockel KH. Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany. Cancer. 2016; 122(3): 432-437. Go to original source... Go to PubMed...
  25. Freedberg KA, Geller AC, Miller DR, et al. Screening for malignant melanoma: A cost-effectiveness analysis. J Am Acad Dermatol. 1999; 41(5 Pt 1): 738-745. Go to original source... Go to PubMed...
  26. Losina E, Walensky RP, Geller A, et al. Visual screening for malignant melanoma: a cost-effectiveness analysis. Arch Dermatol. 2007; 143(1): 21-28. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.